<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
------
Ilex Oncology, Inc.
----------------------------------
(Name of Issuer)
Common Stock $.01 par value
----------------------------------
(Title of Class of Securities)
0004519231
----------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above
Person
Cross Atlantic Partners K/S
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Denmark
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially -0- shares
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With 759,940 shares
--------------------------------------------------
(7) Sole Dispositive Power
-0- shares
--------------------------------------------------
(8) Shared Dispositive Power
759,940 shares
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
759,940 shares
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
6.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
PN
- -------------------------------------------------------------------------------
Page 2 of 15 Pages
<PAGE>
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above
Person
Cross Atlantic Partners K/S II
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Denmark
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially -0- shares
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With 759,940 shares
--------------------------------------------------
(7) Sole Dispositive Power
-0- shares
--------------------------------------------------
(8) Shared Dispositive Power
759,940 shares
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
759,940 shares
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
6.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
PN
- -------------------------------------------------------------------------------
Page 3 of 15 Pages
<PAGE>
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above
Person
CAP/Hambro, L.P.
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Delaware
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially -0-
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With 759,940 shares
--------------------------------------------------
(7) Sole Dispositive Power
-0-
--------------------------------------------------
(8) Shared Dispositive Power
759,940 shares
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
759,940 shares
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
6.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
PN
- -------------------------------------------------------------------------------
Page 4 of 15 Pages
<PAGE>
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above
Person
CAP/Hambro, Inc.
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Delaware
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially -0-
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With 759,940 shares
--------------------------------------------------
(7) Sole Dispositive Power
-0-
--------------------------------------------------
(8) Shared Dispositive Power
759,940 shares
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
759,940 shares
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
6.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
CO
- -------------------------------------------------------------------------------
Page 5 of 15 Pages
<PAGE>
- -------------------------------------------------------------------------------
(1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above
Person
Hambro America, Inc.
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
New York
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially -0-
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With 759,940 shares
--------------------------------------------------
(7) Sole Dispositive Power
-0-
--------------------------------------------------
(8) Shared Dispositive Power
759,940 shares
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
759,940 shares
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
6.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
CO
- -------------------------------------------------------------------------------
Page 6 of 15 Pages
<PAGE>
NOTE: This Statement on Schedule 13G is being filed on behalf of Cross
Atlantic Partners K/S, Cross Atlantic Partners K/S II, CAP/Hambro, L.P.,
CAP/Hambro, Inc. and Hambro America, Inc. CAP/Hambro, L.P. is the sole
general partner of Cross Atlantic Partners, K/S and Cross Atlantic Partners
K/S II. CAP/Hambro, Inc. is the sole general partner of CAP/Hambro, L.P.
Hambro America, Inc. is the sole shareholder of CAP/Hambro, Inc.
ITEM 1(A). NAME OF ISSUER Ilex Oncology, Inc.
- -------------------------------------------------------------------------------
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
11550 IH-10 West Suite 300
San Antonio, TX 78230
- -------------------------------------------------------------------------------
ITEM 2(A). Item 2(b) Item 2(c)
Citizenship or Place
NAME OF PERSON FILING Address of Organization
Cross Atlantic Partners K/S, a c/o Hambro Health Denmark
Danish limited partnership International, Inc.
650 Madison Avenue
New York, NY 10022
Cross Atlantic Partners K/S II, a c/o Hambro Health Denmark
Danish limited partnership International, Inc.
650 Madison Avenue
New York, NY 10022
CAP/Hambro, L.P., the sole c/o Hambro Health Delaware
general partner of Cross International, Inc.
Atlantic Partners K/S and 650 Madison Avenue
Cross Atlantic Partners K/S II New York, NY 10022
CAP/Hambro, Inc., the sole general c/o Hambro Health Delaware
partner of CAP/Hambro, L.P., International, Inc.
which is wholly-owned by 650 Madison Avenue
Hambro America, Inc. New York, NY 10022
Hambro America, Inc., the parent c/o Hambro Health New York
corporation of CAP/Hambro, International, Inc.
Inc. 650 Madison Avenue
New York, NY 10022
ITEM 2(D). TITLE OF CLASS OF SECURITIES Common Stock $.01 par value.
ITEM 2(E). CUSIP NUMBER 0004519231
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b),
CHECK WHETHER THE PERSON FILING IS A
(a) / / Broker or Dealer registered under Section 15 of the
Securities Exchange Act of 1934 (the "Act").
(b) / / Bank as defined in section 3(a)(6) of the Act.
Page 7 of 15 Pages
<PAGE>
(c) / / Insurance Company as defined in section 3(a)(19) of the Act.
(d) / / Investment Company registered under section 8 of the
Investment Company Act of 1940.
(e) / / Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940.
(f) / / Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F) of the Act.
(g) / / Parent Holding Company, in accordance with
Rule 13d-1(b)(ii)(G).
(h) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(H).
None of the above.
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned: As of December 31, 1997, each of the
following is the owner of record of the number of shares of Common
Stock set forth next to its name:
Cross Atlantic Partners K/S 699,505 shares
Cross Atlantic Partners K/S II 36,883 shares
CAP/Hambro, L.P. 0 shares
CAP/Hambro, Inc. 0 shares
Hambro America, Inc. 0 shares
Additionally, Cross Atlantic Partners K/S and Cross Atlantic Partners
K/S II hold presently exerciseable warrants to purchase 14,468 shares
and 9,084 shares, respectively, of Common Stock. Therefore, CAP/Hambro
L.P., CAP/Hambro, Inc., and Hambro America, Inc. (collectively the
"Entities") may be deemed to beneficially own the shares and
exerciseable warrants owned by Cross Atlantic Partners K/S and Cross
Atlantic Partners K/S II. Hence Cross Atlantic Partners K/S, Cross
Atlantic Partners K/S II and the Entities may be deemed to own
beneficially an aggregate of 759,940 shares (Common Stock and
Warrants).
(b) Percent of Class:
Cross Atlantic Partners K/S 6.2%
Cross Atlantic Partners K/S II 6.2%
CAP/Hambro, L.P. 6.2%
CAP/Hambro, Inc. 6.2%
Hambro America, Inc. 6.2%
The foregoing percentages are calculated based on the 12,278,500 shares
of Common Stock reported to be outstanding in the Quarterly Report on
Form 10-Q of Ilex Oncology, Inc. for the quarter ended September 30,
1997, as adjusted pursuant to Rule 13d-3 (d)(1) of the Act.
(c) Number of shares as to which such person has:
Page 8 of 15 Pages
<PAGE>
(i) sole power to vote or to direct the vote
Cross Atlantic Partners K/S 0 shares
Cross Atlantic Partners K/S II 0 shares
CAP/Hambro, L.P. 0 shares
CAP/Hambro, Inc. 0 shares
Hambro America, Inc. 0 shares
(ii) shared power to vote or to direct the vote
Cross Atlantic Partners K/S 759,940 shares
Cross Atlantic Partners K/S II 759,940 shares
CAP/Hambro, L.P. 759,940 shares
CAP/Hambro, Inc. 759,940 shares
Hambro America, Inc. 759,940 shares
(iii) sole power to dispose or to direct the disposition of
Cross Atlantic partners K/S 0 shares
Cross Atlantic Parnters K/S II 0 shares
CAP/Hambro, L.P. 0 shares
CAP/Hambro, Inc. 0 shares
Hambro America, Inc. 0 shares
(iv) shared power to dispose or to direct the disposition of
Cross Atlantic Partners K/S 759,940 shares
Cross Atlantic Partners K/S II 759,940 shares
CAP/Hambro, L.P. 759,940 shares
CAP/Hambro, Inc. 759,940 shares
Hambro America, Inc. 759,940 shares
Cross Atlantic Partners K/S, Cross Atlantic Partners K/S II,
CAP/Hambro, L.P., CAP/Hambro, Inc., and Hambro America, Inc.
expressly disclaim beneficial ownership of any shares of Common
Stock of Ilex Oncology, Inc., except any shares held directly
of record.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following. / /
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable
- -------------------------------------------------------------------------------
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable
- -------------------------------------------------------------------------------
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Page 9 of 15 Pages
<PAGE>
Not applicable. Cross Atlantic Partners K/S, Cross Atlantic Partners
K/S II, CAP/Hambro, L.P., CAP/Hambro, Inc., and Hambro America, Inc.
expressly disclaim membership in a "group" as defined in Rule 13d-1(b)
(ii)(H).
- -------------------------------------------------------------------------------
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable
- -------------------------------------------------------------------------------
ITEM 10. CERTIFICATION
Not applicable. This statement on Schedule 13G is not filed pursuant
to Rule 13d-1(b).
Attached as Exhibit 1 hereto is a Joint Filing Agreement executed by each of
the filing persons pursuant to Rule 13d-1(f) under Section 13(d) of the Act.
Page 10 of 15 Pages
<PAGE>
Signature
After reasonable inquiry and to the best of his, her or its knowledge
and belief, each of the undersigned certifies that the information set forth
in this statement is true, complete and correct. We also hereby agree to
file this statement jointly pursuant to the agreement set forth as
Exhibit 1 hereto.
Dated: February 13, 1998
---
CROSS ATLANTIC PARTNERS K/S
By: CAP/HAMBRO, L.P.
Its General Partner
By: CAP/HAMBRO, INC.
Its General Partner
By: *
------------------------------
Charles L. Dimmler, III
Authorized Officer
CROSS ATLANTIC PARTNERS K/S II
By: CAP/HAMBRO, L.P.
Its General Partner
By: CAP/HAMBRO, INC.
Its General Partner
By: *
-----------------------------
Charles L. Dimmler, III
Authorized Officer
CAP/HAMBRO, L.P.
By: CAP/HAMBRO, INC.
Its General Partner
By: *
-----------------------------
Charles L. Dimmler, III
Authorized Officer
CAP/HAMBRO, INC.
By: *
-----------------------------
David Barnett
Authorized Officer
HAMBRO AMERICA, INC.
By: *
-----------------------------
David Barnett
Authorized Officer
Page 11 of 15 Pages
<PAGE>
*By: /s/ Lisa C. Torch
------------------------------
Lisa C. Torch
Attorney-in-fact
* This Schedule 13G was executed by Lisa C. Torch pursuant to Powers of
Attorney attached hereto as Exhibit 2.
Page 12 of 15 Pages
<PAGE>
Exhibit 1
AGREEMENT
Pursuant to Rule 13d-1(f) (1) under the Securities Exchange Act
of 1934, the undersigned hereby agree that only one statement containing
the information required by Schedule 13G need be filed with respect to the
ownership by each of the undersigned of shares of Common Stock of Ilex
Oncology, Inc.
This Agreement may be executed in any number of counterparts,
each of which shall be deemed an original.
EXECUTED this 13th day of February, 1998.
---
CROSS ATLANTIC PARTNERS K/S
By: CAP/HAMBRO, L.P.
Its General Partner
By: CAP/HAMBRO, INC.
Its General Partner
By: *
------------------------------
Charles L. Dimmler, III
Authorized Officer
CROSS ATLANTIC PARTNERS K/S II
By: CAP/HAMBRO, L.P.
Its General Partner
By: CAP/HAMBRO, INC.
Its General Partner
By: *
------------------------------
Charles L. Dimmler, III
Authorized Officer
CAP/HAMBRO, L.P.
By: CAP/HAMBRO, INC.
Its General Partner
By: *
-----------------------------
Charles L. Dimmler, III
Authorized Officer
CAP/HAMBRO, INC.
By: *
-----------------------------
David Barnett
Authorized Officer
Page 13 of 15 Pages
<PAGE>
HAMBRO AMERICA, INC.
By: *
-----------------------------
David Barnett
Authorized Officer
*By: /s/ Lisa C. Torch
------------------------------
Lisa C. Torch
Attorney-in-fact
* This Agreement was executed by Lisa C. Torch pursuant to Powers
of Attorney attached hereto as Exhibit 2.
Page 14 of 15 Pages
<PAGE>
Exhibit 2
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature
appears below hereby constitutes and appoints Edwin A. Goodman and Lisa C.
Torch, and each of them, with full power to act without the other, his or
her true and lawful attorney-in-fact, with full power of substitution, to
sign any and all instruments, certificates and documents that may be
necessary, desirable or appropriate to be executed on behalf of himself or
herself as an individual or in his or her capacity as a general partner
of, or an officer of a general partner of, CAP/Hambro, L.P., CAP/Hambro,
Inc., Hambro America, Inc., Cross Atlantic Partners K/S, Cross Atlantic
Partners K/S II and Cross Atlantic Partners K/S III, pursuant to Section 13
or 16 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), and any and all regulations promulgated thereunder, and to file the
same, with all exhibits thereto, and any other documents in connection
therewith, with the Securities and Exchange Commission, and with any other
entity when and if such is mandated by the Exchange Act or by the By-laws
of the National Association of Securities Dealers, Inc., granting unto said
attorney-in-fact full power and authority to do and perform each and
every act and thing necessary, desirable or appropriate, fully to all
intents and purposes as he or she might or could do in person, thereby
ratifying and confirming all that said attorney-in-fact, or his
substitutes, may lawfully do or cause to be done by virtue hereto.
IN WITNESS WHEREOF, this Power of Attorney has been signed as of the
13th day of February, 1998.
- --
/s/ John Cassis
--------------------------
John Cassis
/s/ Charles L. Dimmler, III
---------------------------
Charles L. Dimmler, III
/s/ David Barnett
---------------------------
David Barnett
Page 15 of 15 Pages
